GDTC
Price
$1.92
Change
-$0.01 (-0.52%)
Updated
Nov 13 closing price
Capitalization
22.76M
19 days until earnings call
Intraday BUY SELL Signals
RPRX
Price
$39.73
Change
+$0.14 (+0.35%)
Updated
Nov 13 closing price
Capitalization
16.97B
95 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GDTC vs RPRX

Header iconGDTC vs RPRX Comparison
Open Charts GDTC vs RPRXBanner chart's image
CytoMed Therapeutics
Price$1.92
Change-$0.01 (-0.52%)
Volume$27.71K
Capitalization22.76M
Royalty Pharma
Price$39.73
Change+$0.14 (+0.35%)
Volume$5.13M
Capitalization16.97B
GDTC vs RPRX Comparison Chart in %
GDTC
Daily Signal:
Gain/Loss:
RPRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GDTC vs. RPRX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GDTC is a Hold and RPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (GDTC: $1.93 vs. RPRX: $39.59)
Brand notoriety: GDTC and RPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GDTC: 9% vs. RPRX: 96%
Market capitalization -- GDTC: $22.76M vs. RPRX: $16.97B
GDTC [@Biotechnology] is valued at $22.76M. RPRX’s [@Biotechnology] market capitalization is $16.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GDTC’s FA Score shows that 0 FA rating(s) are green whileRPRX’s FA Score has 2 green FA rating(s).

  • GDTC’s FA Score: 0 green, 5 red.
  • RPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, RPRX is a better buy in the long-term than GDTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GDTC’s TA Score shows that 3 TA indicator(s) are bullish while RPRX’s TA Score has 5 bullish TA indicator(s).

  • GDTC’s TA Score: 3 bullish, 7 bearish.
  • RPRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RPRX is a better buy in the short-term than GDTC.

Price Growth

GDTC (@Biotechnology) experienced а -8.53% price change this week, while RPRX (@Biotechnology) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

GDTC is expected to report earnings on Dec 03, 2025.

RPRX is expected to report earnings on Feb 17, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($17B) has a higher market cap than GDTC($22.8M). RPRX YTD gains are higher at: 58.224 vs. GDTC (-43.235).
GDTCRPRXGDTC / RPRX
Capitalization22.8M17B0%
EBITDAN/A1.93B-
Gain YTD-43.23558.224-74%
P/E RatioN/A22.70-
RevenueN/A2.31B-
Total CashN/A1.49B-
Total DebtN/A8B-
FUNDAMENTALS RATINGS
RPRX: Fundamental Ratings
RPRX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GDTCRPRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
63%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
60%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 25 days ago
86%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
GDTC
Daily Signal:
Gain/Loss:
RPRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRSU34.24-0.09
-0.26%
Pursuit Attractions and Hospitality Inc
O56.93-0.23
-0.40%
Realty Income Corp
SPCE3.62-0.02
-0.55%
Virgin Galactic Holdings
RUN19.44-0.31
-1.57%
Sunrun
JBDI1.11-0.07
-5.93%
JBDI Holdings Ltd

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-1.03%
CYCN - GDTC
35%
Loosely correlated
-11.80%
CVKD - GDTC
29%
Poorly correlated
-0.89%
QSI - GDTC
28%
Poorly correlated
-3.80%
ADIL - GDTC
27%
Poorly correlated
-0.96%
RPRX - GDTC
26%
Poorly correlated
+1.62%
More

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+1.62%
AXON - RPRX
48%
Loosely correlated
-0.47%
MDGL - RPRX
31%
Poorly correlated
-2.32%
ARRY - RPRX
30%
Poorly correlated
-8.69%
QURE - RPRX
29%
Poorly correlated
-2.33%
SLGL - RPRX
28%
Poorly correlated
-1.20%
More